ONCY
ONCOLYTICS (ONCY)
NASDAQ
$0.90-$0.03 (-3.51%)
Price as of Jun 03, 2026 7:56 PM EDT
  • $124.1M
    Market Cap
  • 167.32%
    1-Year Change
  • Biotechnology
    Industry
Annual
Quarterly
12/31/2025
12/31/2024
12/31/2023
12/31/2022
Income Statement
Total Operating Revenue
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cost of Revenue
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Gross Profit
0
N/A
0
N/A
0
N/A
0
N/A
Sales and Marketing Expense
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Research and Development Expense
-13.3M
-38.49%
-21.6M
+22.24%
-17.7M
+14.76%
-15.4M
+19.44%
Depreciation and Amortization Expense
70,000
-41.67%
120,000
+48.15%
81,000
-12.90%
93,000
-28.60%
Total Operating Expenses
28.7M
+115.41%
13.3M
-17.08%
16.1M
+39.94%
11.5M
N/A
Operating Profit
-28.7M
-17.89%
-35.0M
+3.52%
-33.8M
+25.51%
-26.9M
+2.63%
Interest Income
386,000
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Interest Expense
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Interest Income and Expense and Net
386,000
N/A
0
N/A
0
N/A
0
N/A
Total Nonoperating Income and Expense
45,000
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Income before Taxes
-28.7M
-9.56%
-31.7M
+14.26%
-27.8M
+11.75%
-24.8M
-5.59%
Income Taxes
79,000
-39.23%
130,000
+34.02%
97,000
+15.48%
84,000
+69.95%
Extraordinary Items
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Net Income
-28.8M
-9.31%
-31.7M
+14.26%
-27.8M
+11.75%
-24.8M
-5.59%
Net Income from Continuing Operations Applicable to Common
-28.7M
-9.56%
-31.7M
+14.26%
-27.8M
+11.75%
-24.8M
-5.59%
Basic EPS and Net Income
-0.30
-26.83%
-0.41
0.00%
-0.41
-4.65%
-0.43
-12.24%
Diluted EPS and Net Income
-0.30
-26.83%
-0.41
0.00%
-0.41
-4.65%
-0.43
-12.24%
Basic Weighted Average Shares
95.9M
+25.33%
76.5M
+13.10%
67.6M
+16.53%
58.0M
+8.44%
Diluted Weighted Average Shares
95.9M
+25.33%
76.5M
+13.10%
67.6M
+16.53%
58.0M
+8.44%
Balance Sheet
Cash and Cash Equivalents
5.2M
-67.37%
15.9M
-54.34%
34.9M
+199.26%
11.7M
-71.73%
Short-Term Investments
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash and Cash Equivalents and Short-Term Investments
5.2M
-67.37%
15.9M
-54.34%
34.9M
+199.26%
11.7M
-71.73%
Total Current Assets
6.8M
-63.74%
18.9M
-50.55%
38.2M
+6.98%
35.7M
-20.53%
Accumulated Depreciation
526,000
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Property and Plant and Equipment and Net
228,000
-44.53%
411,000
+45.74%
282,000
-20.79%
356,000
-9.19%
Total Long-Term Assets
228,000
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Assets
7.6M
-62.44%
20.2M
-48.00%
38.8M
+3.98%
37.3M
-18.63%
Income Taxes Payable
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Short-Term Debt
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Current Liabilities
6.1M
-8.76%
6.7M
+57.82%
4.2M
+7.40%
3.9M
+46.66%
Total Long-Term Debt
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Long-Term Liabilities
5.3M
-28.26%
7.4M
0.00%
7.4M
N/A
0
-100.00%
Total Liabilities
11.4M
-19.87%
14.2M
+26.18%
11.3M
+3.92%
10.8M
+10.74%
Retained Earnings
-429.5M
-10.09%
-477.7M
+7.11%
-446.0M
+6.64%
-418.3M
+6.31%
Total Stockholders Equity
-3.8M
-163.50%
6.0M
-78.29%
27.6M
+4.00%
26.5M
-26.59%
Total Shares Outstanding
108.0M
N/A
N/A
N/A
N/A
N/A
0
-100.00%
Cash Flow
Cash from Operating Activities
-20.1M
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Capital Expenditures
6,000
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Investing Activities
-6,000
-97.49%
-239,000
-101.18%
20.2M
+199.11%
-20.4M
+7,035.21%
Dividends Paid
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Financing Activities
14.1M
+112.78%
6.6M
-79.26%
32.0M
+162.14%
12.2M
-63.03%
Financials Ratio
Gross Margin
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Operating Margin
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Return on Assets
-207.13%
+92.72%
-107.48%
+47.47%
-72.88%
+22.11%
-59.69%
-8.98%
Return on Equity
-2,633.61%
+1,293.05%
-189.05%
+84.15%
-102.66%
+29.39%
-79.34%
-8.22%
Revenue Growth
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Current Ratio
1.12
-60.26%
2.82
-68.67%
9.01
-0.40%
9.05
-45.82%
Cash Ratio
0.85
-64.24%
2.38
-71.07%
8.24
+178.64%
2.96
-80.72%
Debt-to-Equity Ratio
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Debt-to-Assets Ratio
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A

Earnings & Revenue History

Debt-to-Assets

Cash Flow